BASHH Clinical Effectiveness Group Guidelines
(Last Updated 14th November 2014)
NICE has accredited the process used by the British Association for Sexual Health & HIV (BASHH) to produce its UK national guidelines. Accreditation is valid for 5 years from January 2011. More information on accreditation can be viewed at www.nice.org.uk/accreditation.
For full details on our accreditation visit: www.nice.org.uk/accreditation.
See also the Clinical Effectiveness Group page
- The Draft Chancroid patient information leaflet is now out for public consultation - see below (14th November 2014)
- The Draft Non-gonococcal urethritis patient information leaflet is now out for public consultation - see below (14th November 2014)
- The new Management of Genital Herpes in Pregnancy guideline, produced in association with the RCOG, is now available via the RCOG website - see below (5th November 2014)
- BASHH and EAGA have released an updated position statement regarding the HIV window period - please see below (21st October 2014)
- The Expert Advisory Group on AIDS (EAGA) and the British HIV Association have released a position statement concerning the use of antiretroviral therapy to reduce HIV transmission - see below (6th Oct 2014)
- New Guidance on testing MSM issued - see below (11th Sept 2014)
- The Expert Advisory Group on AIDS (EAGA) has published its recommended change to the HIV post-exposure prophylaxis regimen. It now recommends the use of Truvada + Raltegravir - see below (9th Sept 2014)
- The draft 2014 Chlamydia guideline consultation has now closed. Final document in preparation (3rd Sept 2014)
Draft documents out for public consultation
The following draft documents are out for wider consultation for 6 weeks. Please email the designated contact if you have any comments.
BASHH PATIENT INFORMATION LEAFLETS
Note: BASHH asserts copyright for the patient information contained on this website. It is happy for these materials to be disseminated, in either electronic or paper form, provided the following conditions are met:
(1) The content is not altered in any way (including the presence of the BASHH logo)
(2) That they are not utilised in any way in commercial activities intended to make a profit
The BASHH CEG 2014 summary guidance on tests for Sexually Transmitted Infections (July 2014)
Systemic presentation and complications
Guidelines accepted by National Guideline Clearing House:
- Copyright: most of these guidelines have appeared in print and the copyright belongs to the original publishers (see notice below). They can be freely used for purposes of personal study and education.
- The BASHH National Audit Group has produced a set of audit proformas for conducting audit on certain CEG guidelines. They may be accessed here
Please note: as of October 2014 the membership of the CEG is Dr Keith Radcliffe (Chair), Dr Mark FitzGerald, Dr Deepa Grover, Dr Steve Higgins, Dr Margaret Kingston, Dr Michael Rayment, Dr Darren Cousins, Professor Martin Fisher and Dr Ann Sullivan.
The editors have checked with sources believed to be reliable in their efforts to eliminate error and to provide drug treatment schedules and dosages that are complete and accord with the standards accepted at the time of publication. However, readers are strongly advised to check the information provided is accurate and that changes have not been made in the recommended dose or in the contraindications for administration.
*Guidelines marked with an asterisk
These documents have been published in the International Journal of STD and AIDS and an exclusive licence to publish belongs to SAGE Publications Ltd. Users wishing to download and reproduce this material for purposes other than personal study or education should contact: Rights & Permissions Department, SAGE Publications, 1 Oliver's Yard, 55 City Yard, London EC1Y 1SP, UK. (email@example.com)
Guidelines not marked with an asterisk
BASHH asserts copyright of these guidelines. It is happy for them to be disseminated, in either electronic or paper form, provided the following conditions are met:
1. The content is not altered in any way
2. That they are not utilised in commercial activities intended to make a profit
When citing the guidelines on the web, please give the full title of the guideline, followed by the name/names of the author(s) (in the same way as for paper publications), followed by the full web address and the date when it was accessed. E.g., National Guideline on the Management of Non-gonococcal Urethritis. Horner P J, Shahmanesh M. www.bashh.org/guidelines/2002/NGU 09 01c.pdf [accessed 22 July 2004].
OTHER CLINICAL GUIDANCE ENDORSED BY BASHH